Cochlear Share Price and Company Fundamentals
Last traded: Today at 6:11 AM
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Key Metrics
PE ratio
62.38
PB ratio
5.30
Dividend yield
1.84%
Beta
0.26
Market cap
$9.22B
Enterprise value
$9.24B
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Full time employees | 5400 |
| Website | https://www.cochlear.com |
| Mailing address | 1 University Avenue Macquarie University Sydney NSW 2109 Australia |
| Phone / Fax | 61 2 9428 6555 / 61 2 9428 6353 |
Dividends
More: Cochlear Dividend history, yield and payout ratio
Dividend yield
1.84%
Dividend amount
$2.60
Payout ratio
190.94%
5Y Avg. yield
-%
Cochlear paid $2.60 dividend and the ex-dividend date was 21 Sep 2026.The dividend payout ratio is 190.94%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.COH dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Cochlear.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, President & Executive Director | 58 | |
| Dr. Sarah Thom | Chief Financial Officer | ||
| Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 60 | |
| Ms. Karen O'Driscoll | Chief Information Officer | ||
| Ms. Kristina Devon | VP of Corporate Strategy & Investor Relations | ||
| Mr. Rob McGrory | Group General Counsel & Company Secretary | ||
| Ms. Jennifer Stevenson | VP of Corporate Communications & Brand | ||
| Mr. Dean Phizacklea | Senior Vice President of Global Strategic Marketing | ||
| Ms. Sabina Sopov | Chief People Officer, Global People & Culture | ||
| Mr. Greg Bodkin BE (Hons), MComm (UNSW) | Senior Vice President of Global Supply Chain |
Profitability and management effectiveness
Profit margin
6.27%
Operating margin
14.33%
Return on assets
9.71%
Return on equity
7.98%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cochlear is 9.22B and its enterprise value is 9.24B. The enterprise value to revenue ratio of COH is 3.94. The enterprise value to EBITDA ratio of COH is 19.26.
The COH's stocks Beta value is 0.26 making it 74% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Cochlear (COH)
- Ansell (ANN)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cochlear (ASX:COH) Frequently Asked Questions
1. What is Cochlear's Stock Symbol?
Cochlear trades on ASX under the ticker symbol "COH".
2. What is Cochlear's stock price today?
One share of COH stock can currently be purchased for approximately $140.97.
3. How can I contact Cochlear?
Cochlear's mailing address is 1 University Avenue Macquarie University Sydney NSW 2109 Australia. The company can be reached via phone at 61 2 9428 6555.
4. What is Cochlear's official website?
The official website of Cochlear is https://www.cochlear.com.